Best Patient Engagement Platforms for Telehealth CEOs (2025 Guide)

Introduction: Why Engagement Platforms = Retention Engines

In telehealth, the biggest hidden growth lever isn’t ads — it’s engagement.

• Every no-show is wasted CAC.
• Every refill reminder boosts LTV.
• Every patient follow-up builds retention.

👉 Engagement platforms are no longer “nice-to-have.” They’re the infrastructure of valuation.

In this guide, we’ll compare three top patient engagement platforms — Twilio Health, OhMD, and Updox — and show which is best for SMB startups, mid-market roll-ups, and enterprise-scale telehealth companies.

Section 1: Why Engagement = Valuation

• CAC protection → lower no-shows = more revenue per marketing dollar.
• Retention flywheel → reminders and refills extend patient lifetime value.
• Investor optics → boards ask: “How sticky is your patient base?”

If your engagement stack looks fragile, your valuation multiple shrinks.

Section 2: Twilio Health (API-First, Enterprise-Grade)

• Strengths: API-first, HIPAA-compliant SMS/voice/video, global scale.
• Weaknesses: Requires engineering, usage-based costs.
• Best Fit: Growth-stage/enterprise telehealth with dev resources.
• Investor Lens: Enterprise-ready. Strong if CAC → LTV impact is reported.

👉 [Read Full Twilio Health Review]

Section 3: OhMD (Plug-and-Play Messaging for SMBs)

• Strengths: HIPAA-safe texting, patient-friendly, low IT lift.
• Weaknesses: Not enterprise-ready, limited analytics.
• Best Fit: SMB telehealth practices, niche startups (GLP-1, TRT, mental health).
• Investor Lens: Solid for SMB exits; less credible for PE diligence.

👉 [Read Full OhMD Review]

Section 4: Updox (All-in-One Messaging + Video)

• Strengths: Combines secure chat, video visits, and reminders in one tool.
• Weaknesses: Feature breadth > depth, not enterprise-grade.
• Best Fit: SMB/mid-market telehealth needing bundled engagement + video.
• Investor Lens: Strong for <$100M exits; enterprise needs more scale.

👉 [Read Full Updox Review]

‍

Section 6: Which Should You Choose?

If You’re a Startup (<$10M ARR, specialty focus):

• OhMD → fastest adoption, HIPAA-safe messaging without IT lift.

If You’re Mid-Market (10–200 providers, PE-backed):

• Updox → bundled video + messaging → lower vendor sprawl.

If You’re Growth-Stage/Enterprise ($10M+ ARR, pursuing payer contracts):

• Twilio Health → enterprise-safe, scalable, board-ready.

Section 7: Investor Perspective

Fragile story:

“We just email or text patients on Gmail.”

• Investors hear: compliance risk, fragile retention.

Defensible story:

“We use OhMD/Updox for HIPAA-safe reminders and re-engagement. LTV improved 25%.”

• Investors hear: credible growth discipline.

Moat story:

“We layered Twilio Health engagement into Freshpaint analytics. CAC → LTV improved 45%, payer contracts renewed faster. Engagement is our moat.”

• Investors hear: valuation multiple justification.

Section 8: Verdict

• Twilio Health → Enterprise-ready, but dev-heavy.
• OhMD → SMB-friendly, fast to deploy.
• Updox → All-in-one suite for SMB/mid-market.

👉 The right choice depends on your growth stage + exit strategy.

CTA: Why Engagement Defines Your Exit Story

Engagement isn’t about messages. It’s about valuation math.

That’s why I built the Growth Clarity Diagnostic™.

In one session, we’ll:

• Audit your engagement platform.
• Map CAC → LTV impact.
• Build an investor-ready retention roadmap.

👉 [Book your Growth Clarity Diagnostic™ here.]

FAQ

Which patient engagement platform is best for startups?

OhMD.

Which is best for mid-market telehealth?

Updox.

Which is best for enterprise telehealth?

Twilio Health.

Do all three support HIPAA compliance?

Yes, all provide BAAs.

Which is most investor-ready?

Twilio Health (enterprise), Updox (mid-market), OhMD (SMB exits).

‍